Rachel L. Yung

Rachel L. Yung, MD, is an Associate Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine and holds a joint appointment as Associate Professor in the Clinical Research Division at Fred Hutchinson Cancer Center (Fred Hutch). She is a medical oncologist specializing in breast cancer research, with a focus on improving treatment outcomes and reducing therapy side effects. Dr. Yung leads clinical trials exploring cancer cell signatures and lifestyle impacts on cancer care, survivorship, and prevention.

Affiliations:
- Director, Breast and Ovarian Cancer Prevention Clinic (Fred Hutch)
- Director, Women's Wellness Clinic (Fred Hutch)

Education:
- MD, Harvard Medical School
- BS, University of Nebraska
- Research and Clinical Fellowships in Medical Oncology at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Massachusetts General Hospital
- Residency/Internship in Internal Medicine at Beth Israel Deaconess Medical Center

Research Focus: Her work emphasizes lifestyle’s role in cancer care quality, patient-reported outcomes, and precision oncology. Dr. Yung is advancing new therapies through Fred Hutch’s clinical trials program, including studies on dormancy in breast cancer and adjuvant chemotherapy strategies. She advocates for integrating research opportunities into patient care to improve outcomes and reduce toxicity.

Clinical Trials Leadership: Investigator on trials such as the Phase II "PALAVY" study (targeting dormant breast cancer) and the Phase III OFSET trial (evaluating chemotherapy in premenopausal breast cancer patients).